GNAS and pancreatic intraductal papillary-mucinous neoplasm: The prevalence of GNAS mutations differs per morphological subtype: 100% in the intestinal type, 71% in the pancreatobiliary type, 51% in the gastric type and 0% in the oncocytic-type IPMN [75].